Literature DB >> 11897568

3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling.

Peter Storz1, Alex Toker.   

Abstract

The recently discovered 3'-phosphoinositide-dependent kinase-1 (PDK-1) is a serine/threonine protein kinase which phosphorylates several members of the conserved AGC kinase superfamily (comprising the prototypes protein kinases A (PKA), G (PKG) and C (PKC)). Phosphorylation of a threonine or serine residue in the activation loop (also known as the T-loop) of these kinases is a critical step in their activation, and is typically accompanied by additional phosphorylations elsewhere in the molecule. Phosphorylation of the activation loop is a common regulatory mechanism shared by most serine/threonine as well as tyrosine kinases as it facilitates alignment of amino acid residues in the active site which are involved in the phosphotransferase reaction. Therefore the discovery of PDK-1 as the enzyme which mediates this event in many protein kinases introduced a new and important step in signaling pathways which regulate numerous important cellular processes including cellular survival, glucose transport and metabolism, tumor progression as well as protein translation. Moreover, the finding that PDK-1 function is mediated in part by the phosphoinositide 3'-OH-kinase (PI 3-K) pathway also provided an explanation as to how the lipid products of PI 3-K, namely phosphatidylinositol-3,4-bisphosphate (PtdIns-3,4-P2) and phosphatidylinositol-3,4-5-trisphosphate (PtdIns-3,4,5-P3) stimulate the activation of protein kinase-dependent signaling pathways. These initial landmark observations were followed by many important studies which provided additional mechanistic insight into both PDK-1 regulation as well as the role of this kinase in cellular function. This review will focus on the regulation of PDK-1 and the various mechanisms which it uses to contribute to the activation of target kinases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897568     DOI: 10.2741/storz

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  27 in total

1.  Protein kinase B/Akt modulates nephrotoxicant-induced necrosis in renal cells.

Authors:  Zabeena P Shaik; E Kim Fifer; Grazyna Nowak
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-29

2.  A new approach to the molecular analysis of docking, priming, and regulated membrane fusion.

Authors:  Tatiana P Rogasevskaia; Jens R Coorssen
Journal:  J Chem Biol       Date:  2011-02-08

Review 3.  Reactive oxygen species in cancer.

Authors:  Geou-Yarh Liou; Peter Storz
Journal:  Free Radic Res       Date:  2010-05

4.  Dissecting the mechanism of insulin resistance using a novel heterodimerization strategy to activate Akt.

Authors:  Yvonne Ng; Georg Ramm; David E James
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

5.  Cross-talk between STAT1 and PI3K/AKT signaling in HIV-1-induced blood-brain barrier dysfunction: role of CCR5 and implications for viral neuropathogenesis.

Authors:  Bo Yang; Sangya Singh; Rafael Bressani; Georgette D Kanmogne
Journal:  J Neurosci Res       Date:  2010-11-01       Impact factor: 4.164

6.  Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation.

Authors:  Michael P Scheid; Michael Parsons; James R Woodgett
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes.

Authors:  Stephen A Whelan; Wagner B Dias; Lakshmanan Thiruneelakantapillai; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

8.  c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms.

Authors:  Maria Lodeiro; Marily Theodoropoulou; Maria Pardo; Felipe F Casanueva; Jesus P Camiña
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

9.  Structure-based CoMFA and CoMSIA study of indolinone inhibitors of PDK1.

Authors:  Kirandeep Kaur; Tanaji T Talele
Journal:  J Comput Aided Mol Des       Date:  2008-09-09       Impact factor: 3.686

Review 10.  The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.

Authors:  Motoyasu Saji; Matthew D Ringel
Journal:  Mol Cell Endocrinol       Date:  2009-11-06       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.